This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Xeris Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Michael Riddell: Innovator in Diabetes Management
Introduction
Michael Riddell is a prominent inventor based in Chicago, IL, who has made significant contributions to the field of diabetes management. His innovative work focuses on addressing exercise-induced hypoglycemia, a critical concern for individuals with type 1 and type 2 diabetes.
Latest Patents
Riddell holds a patent for the "Treatment of exercise-induced hypoglycemia in type 1 and insulin using type 2 diabetes." This patent outlines methods for treating, ameliorating, or preventing exercise-induced or exercise-associated hypoglycemia. The invention involves administering a formulation of glucagon or glucagon analog to a subject in need, effectively managing their condition during physical activity.
Career Highlights
Michael Riddell is associated with Xeris Pharmaceuticals, Inc., where he continues to develop innovative solutions for diabetes care. His work is instrumental in improving the quality of life for individuals managing diabetes, particularly during exercise.
Collaborations
Riddell collaborates with Brett Newswanger, contributing to advancements in diabetes treatment and research.
Conclusion
Michael Riddell's contributions to diabetes management through his innovative patent demonstrate his commitment to improving health outcomes for individuals with diabetes. His work continues to inspire advancements in the field.